HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report.

Abstract
We present a 48-year-old woman with Parkinson's disease in whom carbidopa was added to Mucuna pruriens, resulting in marked motor improvement (documented on video and using MDS-UPDRS motor scores). This case report shows that adding a dopa-decarboxylase inhibitor (DDCI) to Mucuna pruriens could fit well in a personalized approach for patients who are reluctant to start levodopa. Meanwhile, larger trials with a longer follow-up are needed to establish the true effects and tolerability of Mucuna pruriens plus a DDCI.
AuthorsDanique L M Radder, Andreas T Tiel Groenestege, Inge Boers, Eline W Muilwijk, Bastiaan R Bloem
JournalJournal of Parkinson's disease (J Parkinsons Dis) Vol. 9 Issue 2 Pg. 437-439 ( 2019) ISSN: 1877-718X [Electronic] Netherlands
PMID30856121 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Video-Audio Media)
Chemical References
  • Aromatic Amino Acid Decarboxylase Inhibitors
  • Plant Preparations
  • Carbidopa
Topics
  • Aromatic Amino Acid Decarboxylase Inhibitors (therapeutic use)
  • Carbidopa (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Middle Aged
  • Mucuna
  • Parkinson Disease (drug therapy)
  • Patient Preference
  • Phytotherapy
  • Plant Preparations (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: